Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 3, Issue 4, 2007, Pages 281-296

  Balogh, Lajos ^a   Nigavekar, Shraddha S ^b   Nair, Bindu M ^a   Lesniak, Wojciech ^a   Zhang, Chunxin ^b   Sung, Lok Yun ^b   Kariapper, Muhammed S T ^a   El Jawahri, Areej ^b   Llanes, Mikel ^b   Bolton, Brian ^b   Mamou, Fatema ^b   Tan, Wei ^a   Hutson, Alan ^a   Minc, Leah ^c   Khan, Mohamed K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Composite nanodevice; Melanoma; Nanocomposite; PAMAM dendrimer; Tumor biodistribution

Indexed keywords

DISEASES; DRUG DELIVERY; MEDICAL IMAGING; NANOSTRUCTURED MATERIALS; TUMORS;

CANCER IMAGING; COMPOSITE NANODEVICES (CND); INORGANIC NANOPARTICLES;

LIVING SYSTEMS STUDIES;

DENDRIMER; GOLD; NANOMATERIAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; COMPOSITE MATERIAL; CONTROLLED STUDY; ELECTRICITY; EXCRETION; IN VIVO STUDY; MALE; MELANOMA B16; MOUSE; NANODEVICE; NONHUMAN; PARTICLE SIZE; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RAT; SURFACE PROPERTY;

ANIMALS; CELL LINE, TUMOR; GOLD; MALE; MELANOMA; MICE; MICE, INBRED C57BL; MICE, NUDE; NANOPARTICLES; ORGAN SPECIFICITY; PARTICLE SIZE; PROSTATIC NEOPLASMS; TISSUE DISTRIBUTION;

EID: 36749089482     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2007.09.001     Document Type: Article

References (40)

1. Balogh L., Swanson D.R., Spindler R., and Tomalia D.A. Formation and characterization of dendrimer-based water soluble inorganic nanocomposites. Proceedings of the Division of Polymeric Materials Science and Engineering, American Chemical Society 77 (1997) 118-119
2. Balogh L., and Tomalia D.A. Dendrimer-templated nanocomposites I. Synthesis of zero-valent copper nanoclusters. J Am Chem Soc 120 (1998) 7355-7356
3. Tomalia DA, Balogh L. Nanocomposites of dendritic polymers. United States patent US 6664315 B2. Dec 16 2003.
4. Tomalia DA, Balogh L. Nanocomposites of dendritic polymers. United States patent US 6995234. Feb 7 2006.
5. Zhao M., Sun L., and Crooks R.M. Preparation of Cu nanoclusters within dendrimer templates. J Am Chem Soc 120 (1998) 4877-4878
6. Khan M.K., Nigavekar S.S., Minc L.D., Kariapper M.S.T., Nair B.M., and Lesniak W.G. In vivo biodistribution of dendrimers and dendrimer nanocomposites-implications for cancer imaging and therapy. Technol Cancer Res Treat 4 (2005) 603-613
7. Balogh L., Bielinska A., Eichman J.D., Valluzi R., Lee I., Baker J.R., et al. Dendrimer nanocomposites in medicine. Chim Oggi (Chemistry Today) 20 (2002) 35-40
8. Bielinska A., Kukowska-Latallo J.F., Johnson J., Tomalia D.A., and Baker Jr. J.R. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res 24 (1996) 2176-2182
9. Delong R., Stephenson K., Loftus T., Fisher M., Alahari S., Nolting A., et al. Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery. J Pharm Sci 86 (1997) 762-764
10. Kukowska-Latallo J.F., Bielinska A.U., Johnson J., Spindler R., Tomalia D.A., and Baker Jr. J.R. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci U S A 93 (1996) 4897-4902
11. Malik N., Evagorou E.G., and Duncan R. Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs 10 (1999) 767-776
12. 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 65 (2000) 133-148
13. Roberts J.C., Bhalgat M.K., and Zera R.T. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res 30 (1996) 53-65
14. Wiener E.C., Konda S., Shadron A., Brechbiel M., and Gansow O. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Invest Radiol 32 (1997) 748-754
15. Balogh L., Valuzzi R., Laverdure K.S., Gido S.P., Hagnauer G.L., and Tomalia D.A. Formation of silver and gold dendrimer nanocomposites. J Nanopart Res 1 (1999) 353-368
16. 0-PAMAM} gold-dendrimer nanocomposites in cells. J Nanopart Res 4 (2002) 395-403
17. Tomalia D.A., Baker H., Dewald J.R., et al. Polym J (Tokyo) 17 (1985) 117-132
18. Kukowska-Latallo J.F., Candido K.A., Cao Z., et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 65 (2005) 5317-5324
19. 3H dendrimer nanoparticle organ/tumor distribution. Pharm Res 21 (2004) 476-483
20. Esumi K., Suzuki A., Aihara N., Usui K., and Torigoe K. Preparation of gold colloids with UV irradiation using dendrimers as stabilizer. Langmuir 14 (1998) 3157-3159
21. Garcia M.E., Baker L.A., and Crooks R.M. Preparation and characterization of dendrimer-gold colloid nanocomposites. Anal Chem 71 (1999) 256-258
22. Ottaviani M.F., Valluzzi R., and Balogh L. Internal structure of silver-poly(amidoamine) dendrimer complexes and nanocomposites. Macromolecules 35 (2002) 5105-5115
23. Esumi K. Dendrimers for nanoparticle synthesis and dispersion stabilization. Top Curr Chem 227 (2003) 31-52
24. Martin C.R. Nanomaterials: a membrane-based synthetic approach. Science 266 (1994) 1961-1966
25. Lesniak W., Bielinska A.U., Sun K., et al. Silver/dendrimer nanocomposites as biomarkers: fabrication, characterization, in vitro toxicity, and intracellular detection. Nano Lett 5 (2005) 2123-2130
26. Root S.W., Andrews G.A., Knieseley R.M., and Tyor M.P. The distribution and radiation effects of intravenously administered colloidal Au 198 in man. Cancer 7 (1954) 856-866
27. Rubin P., and Levitt S.H. The response of disseminated reticulum cell sarcoma to the intravenous injection of colloidal radioactive gold. J Nucl Med 5 (1964) 581-594
28. Balogh L.P., and Khan M.K. Dendrimer nanocomposites for cancer therapy. In: Amiji M.M. (Ed). Nanotechnology for cancer therapy (2007), CRC Press-Taylor & Francis Group, Boca Raton (Fla) 551-592
29. Holm H.H. The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol 13 (1997) 431-437
30. Uppuluri S., Swanson D.R., Piehler L.T., Li J., Hagnauer G.L., and Tomalia D.A. Core-shell tecto(dendrimers): I. Synthesis and characterization of saturated shell models. Adv Mater 12 (2000) 796-800
31. Balogh L.P., Valluzzi G.L., Hagnauer G.L., Laverdure K.S., Gido S.P., and Tomalia D.A. Formation of silver and gold dendrimer nanocomposites. J Nanopart Res 1 (1999) 353-368
32. Balogh L.P., Nigavekar S.S., Cook A.C., Minc L., and Khan M.K. Development of dendrimer-gold radioactive nanocomposites to treat cancer microvasculature. Pharmachem 2 (2003) 94-99
33. Burda C., Chen X., Narayanan R., and El-Sayed M.A. Chemistry and properties of nanocrystals of different shapes. Chem Rev 105 (2005) 1025-1102
34. Balogh L., Ganser T.R., and Shi X. Characterization of dendrimer-gold nanocomposite materials. Paper presented at Materials Research Society Symposium Proceedings, 2005, Warrendale, PA (2005)
35. Zheng J, Zhang C, Dickson RM. Highly flourescent, water-soluble size-tunable gold quantum dots. Phys Rev Lett 2004;93:077402-1-4.
36. 2 gel layers. Chem Mater 11 (1999) 33-35
37. Doremus R.H., and Rao P. Optical properties of nanosized gold particles. J Mat Res 11 (1996) 2834-2840
38. He J.A., Valluzzi R., Yang R., et al. Electrostatic multilayer deposition of a gold-dendrimer nanocomposite. Chem Mater 11 (1999) 3268-3274
39. El-Sayed M., Kiani M.F., Naimark M.D., Hikal A.H., and Ghandehari H. Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium. Pharm Res 18 (2001) 23-28
40. Shi X., Majoros I.J., and Baker Jr. J.R. Capillary electrophoresis of poly(amidoamine) dendrimers: from simple derivatives to complex multifunctional medical nanodevices. Mol Pharmacol 2 (2005) 278-294